CPhI North America 2026: CDMO Partnerships With Mikart

Explore key themes shaping pharmaceutical development and manufacturing conversations at three major 2026 industry events. Each post focuses on how sponsors can approach CDMO selection and collaboration more strategically—whether evaluating U.S.-based manufacturing options, planning tech transfer for oral solid dose programs, or advancing complex oral solid and liquid formulations from development to commercialization.

Across conferences geared toward partnering, outsourcing, and formulation science, the blogs examine practical considerations such as supply chain resiliency, integration across development stages, risk mitigation during scale-up, and patient‑centric design for pediatric and geriatric products. Rather than offering surface-level event previews, the posts are designed to help readers prepare for more meaningful, solution‑oriented conversations on the show floor.

Together, the series provides context for why these events matter, what topics are most relevant for attendees, and how sponsors can use them to inform smarter outsourcing and development decisions throughout the product lifecycle.